Quantros, Inc.

Links shared publicly online about this topic.

  • 1,596
    total visits

Quantros, Inc.

quantros.com

Quantros, Inc.

View full resource at quantros.com

Tags: Hospital, Environment, Hospitals, Litigation

  • Share

Most Recently Shared on November 17, 2009 at 1:34 pm By:

Quantros Chris Bethell

Carle Foundation Hospital Expands Quantros SRM for a Safer Care Environment and Reduced Litigation Exposure http://bit.ly/3YAlC1

2 years ago...

Pretest Surgery App Just DoesnÕt Cut It for Board Prep

imedicalapps.com — “This is an app review for the Pretest Surgery App by Modality, Inc., written by a third-year medical student. This app is available for iPhone, iPod touch, and iPad.View full resource at imedicalapps.com

  • View Related
  • Share

Most Recently Shared on May 7, 2012 at 9:00 pm By:

iMedicalApps iMedicalApps.com

Pretest Surgery App Just Doesn't Cut It for Board Prep http://t.co/LTsn2390

5 days ago...

Pfizer Arthritis Pill Raises Safety Concerns, FDA Staff Says - Bloomberg

bloomberg.com — “Pfizer Inc.’s experimental pill to treat rheumatoid arthritis, one of the company’s leading drug candidates, raised “serious safety concerns” in trials, U.S. regulators said today.View full resource at bloomberg.com

  • View Related
  • Share

Most Recently Shared on May 7, 2012 at 5:04 pm By:

iCAD, Breastlink announce agreement to offer Xoft brachytherapy System

news-medical.net — “iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, and Breastlink Medical Group in Southern California, today announced an agreement that will make the Xoft Axxent Electronic Brachytherapy System available to breast cancer patients treated at Breastlink.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on May 5, 2012 at 12:37 pm By:

BreastCancers News-Medical.Net Health News

Breast Cancer News: iCAD, Breastlink announce agreement to offer Xoft brachytherapy System: iCAD, Inc., an indus... http://t.co/VkJuheqM

1 week ago...

Bringing interactive medical lectures to the iPad: Taimma Communications

imedicalapps.com — “The future of eLearning by Taimma Communications Inc on the iPad. These apps deliver fully narrated learning packages to students.View full resource at imedicalapps.com

  • View Related
  • Share

Most Recently Shared on May 4, 2012 at 11:56 pm By:

iMedicalApps iMedicalApps.com

Bringing interactive medical lectures to the iPad: Taimma Communications http://t.co/n4mBtX8T

1 week ago...

AAO

one.aao.org — “AAOView full resource at one.aao.org

  • View Related
  • Share

Most Recently Shared on May 4, 2012 at 8:31 pm By:

aao_ophth AAO Medical Society and Ophthalmology

Another site approved for dry AMD stem cell trial [AAO members] http://t.co/HLkz6iHg

1 week ago...

How Liquid Crystal Displays Work in an eWriter | Boogie Board | Behind the Scenes | LiveScience

livescience.com — “The Boogie Board eWriter developed by Kent Displays, Inc. as an alternative to paper products.View full resource at livescience.com

  • View Related
  • Share

Most Recently Shared on May 4, 2012 at 7:30 pm By:

Drugmakers’ Deal With Obama Said to Be Probed by House - Bloomberg

bloomberg.com — “Pfizer Inc. and Merck & Co. are being pulled into an expanding congressional investigation about the agreement drugmakers reached with the Obama administration to support the Democrats’ overhaul of the U.S. health-care system, according to three people familiar with the talks.View full resource at bloomberg.com

  • View Related
  • Share

Most Recently Shared on May 4, 2012 at 4:17 pm By:

EndoBarrier Re-Implantation Feasible

medicalnewstoday.com — “According to an announcement made by GI Dynamics Inc., new data results demonstrate that the EndoBarrier®, a new device for the treatment of type 2 diabetes and/or obesity, is feasible and caView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 4, 2012 at 4:05 pm By:

HealthPassion HealthPassion Health News

EndoBarrier Re-Implantation Feasible: According to an announcement made by GI Dynamics Inc., new data results de... http://t.co/Y8i8YFjI

1 week ago...

Preview: U.S. panel seen backing Pfizer's arthritis drug hope - Yahoo! News

news.yahoo.com — “From Yahoo! News: WASHINGTON (Reuters) - Pfizer Inc's experimental rheumatoid arthritis drug goes before an advisory panel next week, a potential blockbuster medicine that would revive faith in the company's research if its benefits are deemed to outweigh its side effects. Most industry analysts expect the Food and Drug Administration's expert committee to recommend approval despite risks posed by higher-than-normal cholesterol and liver enzyme levels and infections for patients taking tofacitinView full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on May 4, 2012 at 12:10 pm By:

Arthritis_OW Arthritis OW OW Health and Active Health Library

Preview: U.S. panel seen backing Pfizer's arthritis drug hope: WASHINGTON (Reuters) - Pfizer Inc's experimental ... http://t.co/EuZGvdyn

1 week ago...

Alnylam first quarter revenues decrease to $20.6 million

news-medical.net — “Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today reported its consolidated financial results for the first quarter 2012, and company highlights.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on May 4, 2012 at 9:19 am By:

Oncology_News News-Medical.Net Oncology and Health News

Oncology News: Alnylam first quarter revenues decrease to $20.6 million: Alnylam Pharmaceuticals, Inc., a leadin... http://t.co/Brq3qmdV

1 week ago...

Acupressure Device Effective In Reducing Postoperative Nausea, Vomiting

medicalnewstoday.com — “In a peer-reviewed published study, a new medically engineered pressure-technology disposable adhesive device (Pressure Right®) developed by Pressure Point Inc. has clinically proven to enhancView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 4, 2012 at 8:50 am By:

Drugs_Devices Drugs and Devices OW OW Health

Acupressure Device Effective In Reducing Postoperative Nausea, Vomiting: In a peer-reviewed published... http://t.co/rZQZ25zX #MedDevice

1 week ago...

Affymetrix to acquire eBioscience

news-medical.net — “Affymetrix, Inc., and eBioscience, Inc., a privately-held San Diego, CA-based company with an industry-leading position in flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics, today announced they have amended their existing definitive agreement dated November 29, 2011 under which Affymetrix will acquire eBioscience.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on May 4, 2012 at 6:32 am By:

Oncology_News News-Medical.Net Oncology and Health News

Oncology News: Affymetrix to acquire eBioscience: Affymetrix, Inc., and eBioscience, Inc., a privately-held San ... http://t.co/yd1SLA7e

1 week ago...

Emergent BioSolutions first quarter total revenues increase to $50.3M

news-medical.net — “Emergent BioSolutions Inc. announced today its financial results for the first quarter ended March 31, 2012.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on May 4, 2012 at 6:32 am By:

Oncology_News News-Medical.Net Oncology and Health News

Oncology News: Emergent BioSolutions first quarter total revenues increase to $50.3M: Emergent BioSolutions Inc.... http://t.co/D9Rkx30n

1 week ago...

GenVec receives NIAID’s Phase I SBIR grant to support RSV vaccine program

news-medical.net — “GenVec, Inc. announced today that it has received a Phase I Small Business Innovation and Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to support the Company's Respiratory Syncytial Virus (RSV) vaccine program.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on May 4, 2012 at 6:13 am By:

NewsMedical News-Medical.Net Health News

GenVec receives NIAID’s Phase I SBIR grant to support RSV vaccine program: GenVec, Inc. announced today that it ... http://t.co/jltN39Bf

1 week ago...

Aveo takes 1Q loss as drug development continues - BusinessWeek

businessweek.com — “Aveo Pharmaceuticals Inc. said Thursday it took a loss in the first quarter as it continued development of two experimental cancer drugs.View full resource at businessweek.com

  • View Related
  • Share

Most Recently Shared on May 4, 2012 at 5:45 am By:

Drugs_Devices Drugs and Devices OW OW Health

Aveo takes 1Q loss as drug development continues - BusinessWeek: Updated NewsAveo takes 1Q loss as drug de... http://t.co/NyPVouhZ #drug

1 week ago...

Advertisement